Cue Biopharma, Inc. (CUE) Financials

CUE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 68.9 million 26.2 million
2023-06-30 73.2 million 27.2 million
2023-03-31 81.7 million 26.7 million
2022-12-31 91.3 million 25.6 million

CUE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.8 million 2.1 million
2023-06-30 -10.4 million 2.0 million
2023-03-31 -10.8 million 2.0 million
2022-12-31 -10.5 million 2.1 million

CUE Net Income

No data available :(

CUE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 54.7 million - 7.3 million
2023-06-30 57.9 million 6.1 million 8.0 million
2023-03-31 66.2 million 7.1 million 8.7 million
2022-12-31 76.3 million 8.0 million 9.3 million

CUE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 46.4 million
2023-06-30 44.8 million
2023-03-31 44.7 million
2022-12-31 35.6 million

CUE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 9.9 million 3.6 million -
2023-06-30 - 10.7 million 4.2 million -
2023-03-31 2000 9.4 million 4.2 million -
2022-12-31 746 11.3 million 3.7 million -

CUE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.1 million 857000
2023-06-30 1.4 million 848000
2023-03-31 187000 880000
2022-12-31 151227 580055

CUE

Price: $2.13

52 week price:
1.37
5.12

Earnings Per Share: -1.11 USD

P/E Ratio: -1.89

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 255300

Market Capitalization: 85.1 million

Links: